Kabra Drugs Ltd Board Approves AGM, Director Re-appointment, Auditors

Kabra Drugs Ltd's Board of Directors met on September 2, 2026, approving key corporate actions. The board sanctioned the Director's Report and Corporate Governance Report for the fiscal year ending March 31, 2026. They also approved the notice for the 37th Annual General Meeting (AGM) scheduled for September 30, 2026, in Chennai. The meeting will include the re-appointment of director Mr. Kuniamuthur Nanjappan Anand and the appointment of Ms. Moonam Kapoor as a new director. Additionally, M/s Karthik L & Associates were appointed as Internal Auditors for FY 2026-2027, and Mrs. Twinkle Agarwal was appointed as Secretarial Auditor for five years.